PRLR and breast carcinoma: On the basis of the observation that, in several immunohistochemical studies of patients with breast carcinoma, PRLr is expressed at high levels, the evaluation of PRLr expression should be considered in these patients and should be mandatory in patients diagnosed with PRL-secreting PitNETs.